ISB
TEVA icon

Iowa State Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Iowa State Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-13,098
Closed -$435K – 98
2017
Q2 		$435K Sell
13,098
-1,322
-9% -$40.9K 0.21% 70
2017
Q1 		$463K Sell
14,420
-360
-2% -$12.3K 0.23% 63
2016
Q4 		$536K Buy
14,780
+394
+3% +$15.7K 0.28% 60
2016
Q3 		$662K Sell
14,386
-205
-1% -$10.7K 0.35% 53
2016
Q2 		$733K Buy
14,591
+465
+3% +$24.8K 0.4% 52
2016
Q1 		$756K Buy
14,126
+30
+0.2% +$1.76K 0.43% 50
2015
Q4 		$925K Buy
14,096
+235
+2% +$14.5K 0.55% 48
2015
Q3 		$783K Buy
13,861
+155
+1% +$10.1K 0.54% 46
2015
Q2 		$810K Buy
13,706
+170
+1% +$10.5K 0.51% 47
2015
Q1 		$843K Hold
13,536
– – 0.54% 47
2014
Q4 		$778K Buy
13,536
+461
+4% +$25.7K 0.49% 47
2014
Q3 		$703K Sell
13,075
-130
-1% -$6.89K 0.47% 48
2014
Q2 		$692K Buy
13,205
+250
+2% +$12.8K 0.47% 48
2014
Q1 		$685K Buy
12,955
+1,875
+17% +$86.7K 0.49% 48
2013
Q4 		$444K Sell
11,080
-1,540
-12% -$60.6K 0.33% 54
2013
Q3 		$477K Sell
12,620
-685
-5% -$26.7K 0.37% 53
2013
Q2 		$522K Buy
+13,305
New +$518K 0.43% 53

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Iowa State Bank's TEVA Position: Q3 2017 in Review

Iowa State Bank sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 13,098 shares — an estimated $435K sold.

Iowa State Bank first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $925K in Q4 2015. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Iowa State Bank reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Iowa State Bank sold 13,098 Teva Pharmaceuticals shares in Q3 2017, an estimated $435K.
  • Iowa State Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Iowa State Bank's Teva Pharmaceuticals position peaked at $925K in Q4 2015.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Iowa State Bank's 13F filing for Q3 2017, filed 16 Oct 2017.